• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC HEART VALVES DIVISION MEDTRONIC HALL PROSTHETIC HEART VALVE; HEART-VALVE, MECHANICAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC HEART VALVES DIVISION MEDTRONIC HALL PROSTHETIC HEART VALVE; HEART-VALVE, MECHANICAL Back to Search Results
Model Number M7700
Device Problems Fluid/Blood Leak (1250); Gradient Increase (1270); Perivalvular Leak (1457); Obstruction of Flow (2423); Incomplete Coaptation (2507); Mechanical Jam (2983)
Patient Problems Host-Tissue Reaction (1297); Aortic Regurgitation (1716); Aortic Valve Stenosis (1717); Cardiac Arrest (1762); Stroke/CVA (1770); Death (1802); Non specific EKG/ECG Changes (1817); Endocarditis (1834); Hemorrhage/Bleeding (1888); Insufficiency, Valvular (1926); Unspecified Infection (1930); Mitral Valve Stenosis (1965); Renal Failure (2041); Sepsis (2067); Thrombus (2101); Heart Failure (2206); Regurgitation (2259); Stenosis (2263); Regurgitation, Valvular (2335); Blood Loss (2597); Complete Heart Block (2627)
Event Date 08/31/2017
Event Type  Injury  
Manufacturer Narrative
Citation: park b et al.Clinical implication of transaortic mitral pannus removal during repeat cardiac surgery for patients with me chanical mitral valve.Circ j.2018 jan 25;82(2):396-402.Doi: 10.1253/circj.Cj-17-0463.Epub (b)(6) 2017.Earliest date of publish used for event date.No unique device identifier (serial/lot) numbers were provided; without this information it could not be determined whether these observations have been previously reported.If information is provided in the future, a supplemental report will be issued.
 
Event Description
Medtronic received information via literature regarding the safety and feasibility of transaortic mitral pannus removal in patients with rheumatic heart disease on the ventricular side of a mechanical mitral valve through the aortic valve.All data were collected from a single center between february 2004 and december 2016.The study population included 34 patients (predominantly female; mean age 57 years), 6 of which were implanted with a 27 mm medtronic open pivot mechanical valve, 4 were implanted with a 29 mm medtronic open pivot mechanical valve, and 3 were implanted with a medtronic med hall easy-fit mechanical heart valve.No serial numbers were provided.The article defined an early event as any event occurring within 30 days of the surgery.Among all patients, there were no early deaths.There were 4 late deaths: 1 due to heart failure, sepsis from endocarditis in 1 patient, 1 due to chronic renal failure, and death of unknown cause in 1 patient.Based on the available information, none of the deaths were attributed to medtronic product.Among all patients, early adverse events included: 2 permanent pacemaker implantations for heart block and sick sinus syndrome, 1 reoperation because of bleeding, and 1 case of mediastinitis.Other adverse events included: pannus formation, mechanical mitral valve replacement, mitral valve paravalvular leakage and leakage closure, eccentric mitral regurgitation, aortic regurgitation, thrombus, stenosis, high transprosthetic mean pressure gradients, complete immobilization of one cusp, delayed mechanical valve leaflet closure, and extracorporeal membrane oxygenation for cardiac arrest.Late adverse events noted in the article included: 5 cases of cerebral hemorrhage, 2 cases of endocarditis (1 resulting in reoperation and 1 requiring medical treatment), 2 permanent pacemaker implantations for sick sinus syndrome and 1 case of mild mitral paravalvular leakage.Multiple manufacturers were noted in the literature; based on the available information a direct correlation could not be made between the observed adverse events and medtronic product.Among all patients that received a med hall mechanical valve, device malfunctions included: aortic regurgitation caused by acute malfunction of the mechanical mitral valve.Based on the available information, these malfunctions may have been attributed to medtronic product.No additional adverse patient effects or product performance issues were reported.
 
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MEDTRONIC HALL PROSTHETIC HEART VALVE
Type of Device
HEART-VALVE, MECHANICAL
Manufacturer (Section D)
MEDTRONIC HEART VALVES DIVISION
1851 e deere ave
santa ana CA 92705
Manufacturer (Section G)
MEDTRONIC HEART VALVES DIVISION
1851 e deere ave
santa ana CA 92705
Manufacturer Contact
paula bixby
8200 coral sea street ne
mounds view, MN 55112
7635055378
MDR Report Key7690221
MDR Text Key114053378
Report Number2025587-2018-01759
Device Sequence Number1
Product Code LWQ
Combination Product (y/n)N
Reporter Country CodeKS
PMA/PMN Number
P790018
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,l
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 10/05/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/16/2018
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberM7700
Device Catalogue NumberM7700
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received08/08/2018
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age57 YR
-
-